Showing results (481-490 of 506) with videos related to

Sort By:
Pageof 51
JAMA|September 3, 2020
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis, Jonathan A C Sterne, Srinivas Murthy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 18, 2022
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)Ghady Haidar, Mounzer Agha, Andrew Bilderback, et al.
Contemporary Clinical Trials|June 13, 2022
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trialErin K McCreary, J Ryan Bariola, Tami E Minnier, et al.
JAMA Network Open|July 14, 2022
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness TrialDavid T Huang, Erin K McCreary, J Ryan Bariola, et al.
JAMA|October 13, 2025
AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial IntelligenceDerek C Angus, Rohan Khera, Tracy Lieu, et al.
Nature Medicine|June 17, 2022
Redefining critical illnessDavid M Maslove, Benjamin Tang, Manu Shankar-Hari, et al.
The Lancet. Respiratory Medicine|April 18, 2025
Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically illElizabeth S Munroe, Alexandra Spicer, Andrea Castellvi-Font, et al.
Intensive Care Medicine|January 20, 2017
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Andrew Rhodes, Laura E Evans, Waleed Alhazzani, et al.
Critical Care Medicine|January 19, 2017
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Andrew Rhodes, Laura E Evans, Waleed Alhazzani, et al.
Intensive Care Medicine|July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
Pageof 51